Drug Trial Radar · NCT02320032
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
Last checked: Nov 20, 2026Latest source record: Aug 29, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Dec 2014
Primary completion
Apr 2016
Study completion Apr 2016
Sponsor
- Lead sponsor
- Alkermes, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 19, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of various doses and dosing intervals of aripiprazole lauroxil.
Conditions
- Schizophrenia
Interventions
Aripiprazole LauroxilDrug
Gluteal IM injection, given once every 4 to 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- AUC 0-lastTime frame: Up to 45 weeks
- C maxTime frame: Up to 45 weeks
- T maxTime frame: Up to 45 weeks
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Alkermes Investigational Site
Little Rock, Arkansas
Alkermes Investigational Site
Cerritos, California
Alkermes Investigational Site
Garden Grove, California
Alkermes Investigational Site
Washington D.C., District of Columbia
Alkermes Investigational Site
Lauderhill, Florida
Alkermes Investigational Site
Leesburg, Florida
Alkermes Investigational Site
Maitland, Florida
Alkermes Investigational Site
Oakland Park, Florida
Alkermes Investigational Site
Tampa, Florida
Alkermes Investigational Site
Atlanta, Georgia
Alkermes Investigational Site
Chicago, Illinois
Alkermes Investigational Site
Hoffman Estates, Illinois
Alkermes Investigational Site
St Louis, Missouri
Alkermes Investigational Site
Marlton, New Jersey
Alkermes Investigational Site
Austin, Texas
Alkermes Investigational Site
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.